|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0002 USD | +100.00% |
|
0.00% | -50.00% |
| 2023 | Q BioMed Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023 | CI |
| 2023 | Q BioMed Inc. Reports Earnings Results for the Full Year Ended November 30, 2022 | CI |
Q BioMed Inc. reported earnings results for the full year ended November 30, 2022. For the full year, the company reported sales was USD 0.284352 million compared to USD 0.195597 million a year ago. Net loss was USD 2.05 million compared to USD 8.24 million a year ago.
Basic loss per share from continuing operations was USD 0.08 compared to USD 0.33 a year ago. Diluted loss per share from continuing operations was USD 0.08 compared to USD 0.33 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -50.00% | 29.02K | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
Q BIOMED INC. 
